Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03915548 · ClinicalTrials.gov registry record · NA
Optimizing Functional Recovery of Breast Cancer Survivors
A NA study, sponsored by MGH Institute of Health Professions.
- Completed
- Registry status
- NA
- Development phase
- 303
- Enrollment target
NCT03915548: Completed NA study, sponsored by MGH Institute of Health Professions.
NCT03915548 is a NA study that has completed, run by MGH Institute of Health Professions. The registered enrollment target is 303 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03915548, a NA study, has completed, sponsored by MGH Institute of Health Professions.
- COMPLETED
- Registry status
- NA
- Development phase
- 303 participants
- Enrollment target
Study Summary
This study is a randomized controlled trial (RCT) to test the efficacy of a Behavioral Activation and Problem Solving (BA/PS) approach to improving activity participation over time as compared to an attention control condition within a sample of 300 breast cancer survivors reporting reduced activity participation after completing cancer treatment.
Primary Outcome
The Patient Reported Outcomes Measurement Information System (PROMIS): Satisfaction with Social Roles and Activities measures satisfaction with daily routines and activities. Raw scores (ranging 8-40) were converted to T-scores (mean = 50, SD = 10) with higher scores indicating better outcomes (i.e., greater satisfaction with daily routines and activities).
Interventions
- BEHAVIORAL Attention Control Condition
- BEHAVIORAL The Behavioral Activation/ Problem Solving Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2019-08-28 |
| Est. Completion | 2024-03-31 |
| Phase | NA |
What the finished NCT03915548 record still lists
NCT03915548 is an interventional study that assigns participants to a tested intervention. The registered 303 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 2 interventions - of which Attention Control Condition is the first listed.
NCT03915548 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03915548 about?
NCT03915548 is a clinical study titled "Optimizing Functional Recovery of Breast Cancer Survivors". This study is a randomized controlled trial (RCT) to test the efficacy of a Behavioral Activation and Problem Solving (BA/PS) approach to improving activity participation over time as compared to an attention control condition within a sample of 300 breast cancer survivors reporting reduced activity...
What is the current status of trial NCT03915548?
This trial is currently completed. It is a NA study. The enrollment target is 303 participants. The study started on 2019-08-28. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT03915548?
The interventions under investigation include: Attention Control Condition (BEHAVIORAL), The Behavioral Activation/ Problem Solving Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03915548?
This trial is sponsored by MGH Institute of Health Professions, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03915548's enrollment target sits among peer trials
303 329th of 2000 higher than 1,671 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI